Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity.
Kirchhammer N, Trefny MP, Natoli M, Brücher D, Smith SN, Werner F, Koch V, Schreiner D, Bartoszek E, Buchi M, Schmid M, Breu D, Hartmann KP, Zaytseva P, Thommen DS, Läubli H, Böttcher JP, Stanczak MA, Kashyap AS, Plückthun A, Zippelius A. Kirchhammer N, et al. Among authors: hartmann kp. Sci Transl Med. 2022 Jul 13;14(653):eabm9043. doi: 10.1126/scitranslmed.abm9043. Epub 2022 Jul 13. Sci Transl Med. 2022. PMID: 35857639 Free article.
Targeted adenovirus-mediated transduction of human T cells in vitro and in vivo.
Freitag PC, Kaulfuss M, Flühler L, Mietz J, Weiss F, Brücher D, Kolibius J, Hartmann KP, Smith SN, Münz C, Chijioke O, Plückthun A. Freitag PC, et al. Among authors: hartmann kp. Mol Ther Methods Clin Dev. 2023 Feb 26;29:120-132. doi: 10.1016/j.omtm.2023.02.012. eCollection 2023 Jun 8. Mol Ther Methods Clin Dev. 2023. PMID: 37007608 Free PMC article.
DARPin-fused T cell engager for adenovirus-mediated cancer therapy.
Freitag PC, Kolibius J, Wieboldt R, Weber R, Hartmann KP, van Gogh M, Brücher D, Läubli H, Plückthun A. Freitag PC, et al. Among authors: hartmann kp. Mol Ther Oncol. 2024 May 29;32(3):200821. doi: 10.1016/j.omton.2024.200821. eCollection 2024 Sep 19. Mol Ther Oncol. 2024. PMID: 39021370 Free PMC article.
Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action.
Kast F, Schwill M, Stüber JC, Pfundstein S, Nagy-Davidescu G, Rodríguez JMM, Seehusen F, Richter CP, Honegger A, Hartmann KP, Weber TG, Kroener F, Ernst P, Piehler J, Plückthun A. Kast F, et al. Among authors: hartmann kp. Nat Commun. 2021 Jun 18;12(1):3790. doi: 10.1038/s41467-021-23948-6. Nat Commun. 2021. PMID: 34145240 Free PMC article.
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy.
Zhou T, Damsky W, Weizman OE, McGeary MK, Hartmann KP, Rosen CE, Fischer S, Jackson R, Flavell RA, Wang J, Sanmamed MF, Bosenberg MW, Ring AM. Zhou T, et al. Among authors: hartmann kp. Nature. 2020 Jul;583(7817):609-614. doi: 10.1038/s41586-020-2422-6. Epub 2020 Jun 24. Nature. 2020. PMID: 32581358 Free PMC article.
11 results